Prestige V with Havlogen

This page contains information on Prestige V with Havlogen for veterinary use.
The information provided typically includes the following:
  • Prestige V with Havlogen Indications
  • Warnings and cautions for Prestige V with Havlogen
  • Direction and dosage information for Prestige V with Havlogen

Prestige V with Havlogen

This treatment applies to the following species:
Manufacturer: Intervet/Merck Animal Health

ENCEPHALOMYELITIS - RHINOPNEUMONITIS - INFLUENZA VACCINE, EASTERN & WESTERN, KILLED VIRUS, TETANUS TOXOID

A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis virus (Eastern and Western), equine herpesviruses types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains (EIV A/Equine 2/ Kentucky/93 American, EIV A/Equine 2/Kentucky/02 American and EIV A/Equine 2/Newmarket/2/93 Eurasian) and tetanus toxoid. Intervet serological data suggest influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket/1/93, Newmarket/2/93, Suffolk 89 and South Africa 03.

Prestige V with Havlogen Indications

For vaccination of healthy horses 6 months of age or older, as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis viruses and tetanus, as an aid in the control of respiratory disease caused by EIV, EHV-1 and EHV-4 and as an aid in reduction of virus shedding of EIV and EHV-1. Duration of immunity (DOI) has been shown to be at least 6 months for EIV. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

DOSE: For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

CAUTIONS: Store at 2°-7°C (35°-45°F). Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Inject deep into the muscle only. Local reactions may occur at the injection sites in vaccinates. Systemic reactions may also occur in animals following vaccination. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. Contact a physician immediately if an accidental injection occurs.

ANTIBIOTIC: Gentamicin.

PRESERVATIVE: Thimerosal.

Adjuvant: Intervet’s Proprietary Technology

FOR USE IN ANIMALS ONLY

Intervet Inc., Merck Animal Health, division of Intervet Inc., Omaha, NE 68103, USA

U.S. Vet Lic. No 165A

1 800 521-5767 (USA)

1 866 683-7838 (CAN)

For patent information: http://www.merck.com/product/patent/home.html

 

 

Code

 

10 Doses

10 x 1 mL Syringes with Separate Sterile Needles

036486

143745-03

10 Doses

10 mL

036595

136539-03

NAC No.: 10473492

MERCK ANIMAL HEALTH
Intervet Inc.

556 MORRIS AVE., SUMMIT, NJ, 07901
Customer Service:   800-521-5767
Order Desk:   800-648-2118
Technical Service (Companion Animal):   800-224-5318
Technical Service (Livestock):   800-211-3573
Fax:   908-473-5560
Website:   www.merck-animal-health-usa.com
Every effort has been made to ensure the accuracy of the Prestige V with Havlogen information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web5)